These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25431327)

  • 21. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).
    van Aken J; Heimans L; Gillet-van Dongen H; Visser K; Ronday HK; Speyer I; Peeters AJ; Huizinga TW; Allaart CF
    Ann Rheum Dis; 2014 Feb; 73(2):396-400. PubMed ID: 23334213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
    Akdemir G; Heimans L; Bergstra SA; Goekoop RJ; van Oosterhout M; van Groenendael JHLM; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF
    Ann Rheum Dis; 2018 Jan; 77(1):111-118. PubMed ID: 28970207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial.
    Rantalaiho V; Korpela M; Laasonen L; Kautiainen H; Järvenpää S; Hannonen P; Leirisalo-Repo M; Blåfield H; Puolakka K; Karjalainen A; Möttönen T;
    Arthritis Res Ther; 2010; 12(3):R122. PubMed ID: 20576092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.
    Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P
    Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
    Smolen JS; van der Heijde DM; Aletaha D; Xu S; Han J; Baker D; St Clair EW
    Ann Rheum Dis; 2009 Oct; 68(10):1535-40. PubMed ID: 18957487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy.
    Shiozawa K; Yamane T; Murata M; Yoshihara R; Tsumiyama K; Imura S; Shiozawa S
    Arthritis Res Ther; 2016 Feb; 18():55. PubMed ID: 26922083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.
    de Miguel E; Pecondón-Español A; Castaño-Sánchez M; Corrales A; Gutierrez-Polo R; Rodriguez-Gomez M; Pinto-Tasende JA; Rivas JL; Ivorra-Cortés J;
    Rheumatol Int; 2017 Aug; 37(8):1347-1356. PubMed ID: 28389854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.
    Rezaei H; Saevarsdottir S; Forslind K; Albertsson K; Wallin H; Bratt J; Ernestam S; Geborek P; Pettersson IF; van Vollenhoven RF
    Ann Rheum Dis; 2012 Feb; 71(2):186-91. PubMed ID: 21930734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of baseline erosions in undifferentiated arthritis.
    Thabet MM; Huizinga TW; van der Heijde DM; van der Helm-van Mil AH
    Arthritis Res Ther; 2009; 11(5):R155. PubMed ID: 19832979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis.
    Rydell E; Forslind K; Nilsson JÅ; Jacobsson LTH; Turesson C
    Arthritis Res Ther; 2018 May; 20(1):82. PubMed ID: 29720260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab.
    Nishimoto N; Hashimoto J; Miyasaka N; Yamamoto K; Kawai S; Takeuchi T; Murata N; van der Heijde D; Kishimoto T
    Ann Rheum Dis; 2007 Sep; 66(9):1162-7. PubMed ID: 17485422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
    Hambardzumyan K; Bolce R; Saevarsdottir S; Cruickshank SE; Sasso EH; Chernoff D; Forslind K; Petersson IF; Geborek P; van Vollenhoven RF
    Ann Rheum Dis; 2015 Jun; 74(6):1102-9. PubMed ID: 24812287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified baseline prediction model for joint damage progression in rheumatoid arthritis: a step toward personalized medicine.
    de Punder YM; van Riel PL; Fransen J
    J Rheumatol; 2015 Mar; 42(3):391-7. PubMed ID: 25593237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients.
    Végh E; Gaál J; Géher P; Gömöri E; Kovács A; Kovács L; Nagy K; Posta EF; Tamási L; Tóth E; Varga E; Domján A; Szekanecz Z; Szűcs G
    BMC Musculoskelet Disord; 2021 Apr; 22(1):325. PubMed ID: 33794855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
    Yonemoto Y; Okamura K; Takeuchi K; Kaneko T; Kobayashi T; Okura C; Tsushima Y; Takagishi K
    Rheumatol Int; 2016 Jan; 36(1):109-15. PubMed ID: 26232929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Misclassification of disease activity when assessing individual patients with early rheumatoid arthritis using disease activity indices that do not include joints of feet.
    Bakker MF; Jacobs JW; Kruize AA; van der Veen MJ; van Booma-Frankfort C; Vreugdenhil SA; Bijlsma JW; Lafeber FP; Welsing PM
    Ann Rheum Dis; 2012 Jun; 71(6):830-5. PubMed ID: 22128075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study.
    Kubo S; Saito K; Hirata S; Fukuyo S; Yamaoka K; Sawamukai N; Nawata M; Iwata S; Mizuno Y; Tanaka Y
    Mod Rheumatol; 2014 Jan; 24(1):42-51. PubMed ID: 24261758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of initial treatment allocation based on expert opinion for prevention of rapid radiographic progression in daily practice of an early RA cohort.
    Durnez A; Vanderschueren G; Lateur L; Westhovens R; Verschueren P
    Ann Rheum Dis; 2011 Apr; 70(4):634-7. PubMed ID: 21177296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model.
    de Punder YM; Jansen TL; van Ede AE; den Broeder AA; van Riel PL; Fransen J
    J Rheumatol; 2015 Mar; 42(3):398-404. PubMed ID: 25593241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).
    Takeuchi T; Yamanaka H; Inoue E; Nagasawa H; Nawata M; Ikari K; Saito K; Sekiguchi N; Sato E; Kameda H; Iwata S; Mochizuki T; Amano K; Tanaka Y
    Mod Rheumatol; 2008; 18(5):447-54. PubMed ID: 18493716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.